Background: Transcatheter aortic valve implantation (TAVI) has emerged as an important
treatment for patients with severe symptomatic aortic stenosis who are at high operative risk …

Management of coronary artery disease (CAD) in patients with severe aortic stenosis (AS)
referred for transcatheter aortic valve replacement (TAVR) is posing challenges. Due to …

Objectives: The purpose of this study was to evaluate the prevalence of aortic stenosis (AS)
in the elderly and to estimate the current and future number of candidates for transcatheter …

Background Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for
patients with severe aortic stenosis who are not suitable candidates for surgery. The …

Aims This study aimed to assess functional course in elderly patients undergoing
transcatheter aortic valve implantation (TAVI) and to find predictors of functional decline …

Objective To determine the frequency of survival, stroke, atrial fibrillation, structural valve
deterioration, and length of hospital stay after surgical replacement of an aortic valve (SAVR) …

Objectives: This study sought to assess the impact of permanent pacemaker (PPM)
implantation on clinical outcomes among patients undergoing transfemoral transcatheter …

Objectives: This study sought to identify the incidence, predictors, and prognostic impact of
bleeding complications (BC) after surgical aortic valve replacement (SAVR) compared with …

Background—Pulmonary hypertension (PH) frequently coexists with severe aortic stenosis,
and PH severity has been shown to predict outcomes after transcatheter aortic valve …

Objectives: The aim of this study was to examine the frequency, timing, and association of
access-site and non–access-site bleeding with mortality in the setting of transcatheter aortic …